Table 1 |
||||
| Subject information. Data is average ± s.e | ||||
| Sex (M/F) | Age (years) | FEV1(l) | FEV1/FVC (%) | |
| COPD transplant patients (n = 11) | 6/5 | 52.9 ± 2.4 | 0.6 ± 0.1 | 28.3 ± 6.9 |
Ratcliffe and Dougall BMC Pharmacology and Toxicology 2012 13:15 doi:10.1186/2050-6511-13-15
